Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy.

Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy. Abstract Text:

M Steffen,M Cornberg,P Buggisch,

Over the last decade, enormous advances have been achieved in the treatment of chronic hepatitis C. However, the success of the established standard therapy with PEG-IFN and ribavirin is limited and needs further therapeutic options especially for the difficult-to-treat patients with genotype 1, patients with liver cirrhosis, patients with relapse or breakthrough and non-responders after a PEG-IFN/ribavirin combination therapy. In those cases, a daily treatment with CIFN/ribavirin could be a promising concept, before considering non-curable concepts as the long-term IFN maintenance therapy, especially in cases with advanced liver fibrosis. Daily treatments need high motivated and compliant patients. Concepts to optimize current therapies as the use of CIFN or the high dose PEG-IFN therapy are necessary until new kinds of therapy are available.

Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy. Publishing Authors By Initials

M Steffen,M Cornberg,P Buggisch,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hepato-gastroenterology

VOLUME: 54

Page Numbers: 2368-72

Journal Abbreviation: Hepatogastroenterology

ISSN: 0172-6390

DAY: 12

MONTH: Dec

YEAR: 2007

Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8007849

Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy.

AFFILIATION: Medizinische Klinik I, Franziskus Hospital, Bielefeld, Germany. ccjmsteffen@t-online.de

Country: Greece

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hepatogastroenterology

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy Related Publications

• Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy.